Start for free
Start for free
AB

Arkin Bio Ventures

Asia, Tel Aviv, Israel, Herzliya

Description

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech and medical device technologies.

Investor Profile

Arkin Bio Ventures has made 19 investments, with 4 in the past 12 months and 11% as lead.

Stage Focus

  • Series A (47%)
  • Series B (32%)
  • Series C (16%)
  • Seed (5%)

Country Focus

  • United States (84%)
  • Israel (11%)
  • Canada (5%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical
  • Oncology
  • Life Science
  • Biopharma
  • Neuroscience
  • Mental Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arkin Bio Ventures frequently co-invest with?

Qiming Venture Partners USA
Qiming Venture Partners USA
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 6
BrightEdge Fund
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 3
Longwood Fund
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 4
Deerfield
Deerfield
North America, New York, United States, New York
Co-Investments: 3
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
DCVC Bio
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 3
Pontifax
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 4
Partners Innovation Fund
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Arkin Bio Ventures often collaborate with?

FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 3

What are some of recent deals done by Arkin Bio Ventures?

Newleos Therapeutics

Boston, Massachusetts, United States

Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

BiotechnologyNeuroscience
Series AFeb 13, 2025
Amount Raised: $93,500,000
Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series BFeb 4, 2025
Amount Raised: $27,000,000
Bluejay Therapeutics

San Mateo, California, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series CMay 9, 2024
Amount Raised: $182,000,000
Reunion Neuroscience

Toronto, Ontario, Canada

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

BiotechnologyMental HealthPharmaceutical
Series AMay 2, 2024
Amount Raised: $103,000,000
Entact Bio

Watertown, Massachusetts, United States

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

BiopharmaBiotechnologyLife ScienceMedical
Series ADec 6, 2022
Amount Raised: $81,000,000
Photys Therapeutics

Cambridge, Massachusetts, United States

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Biotechnology
Series ASep 8, 2022
Amount Raised: $75,000,000
Bluejay Therapeutics

San Mateo, California, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series BAug 16, 2022
Amount Raised: $41,000,000
Auron Therapeutics

Wellesley, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series AJul 20, 2022
Amount Raised: $48,000,000
Auron Therapeutics

Wellesley, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
SeedJan 28, 2021
Amount Raised: $12,750,000
Werewolf Therapeutics

Cambridge, Massachusetts, United States

Werewolf Therapeutics operates as an oncology biotherapeutics company.

BiotechnologyLife ScienceOncologyTherapeutics
Series BJan 7, 2021
Amount Raised: $72,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator